Publications

International journal of cancer

Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.

01-08-2025

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study.

01-08-2025

International journal of radiation oncology, biology, physics

Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy.

01-07-2025

Sleep medicine

Sleep quality and overall survival among cancer survivors in the Netherlands: A PROFILES registry study.

01-07-2025

International journal of radiation oncology, biology, physics

Toward the End of Planning Target Volume Margins With Online Adaptive Radiation Therapy.

01-07-2025

Bioorganic & medicinal chemistry

Design, Synthesis, and Biological Implications of Autotaxin inhibitors with a Three-Point lock binding mode.

01-07-2025

iScience

A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability.

20-06-2025

European journal of cancer (Oxford, England : 1990)

Efficacy of encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the Dutch Melanoma Treatment Registry.

18-06-2025

JCI insight

G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor.

09-06-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Biomarker analysis and treatment dynamics following preoperative ipilimumab plus nivolumab in locally advanced urothelial cancer from the phase 1B NABUCCO study.

06-06-2025

European radiology

Post-processing steps improve generalisability and robustness of an MRI-based radiogenomic model for human papillomavirus status prediction in oropharyngeal cancer.

06-06-2025

Nature medicine

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

05-06-2025

Molecular cell

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

05-06-2025

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

05-06-2025

Cellular and molecular life sciences : CMLS

CD151 interacts with integrin beta 2 in B cell lymphomas.

04-06-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast density changes after risk-reducing salpingo-oophorectomy in women with a pathogenic germline variant in BRCA1 or BRCA2.

04-06-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

03-06-2025

European journal of cancer (Oxford, England : 1990)

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

03-06-2025

European journal of cancer (Oxford, England : 1990)

Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.

03-06-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

03-06-2025

International journal of cancer

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

02-06-2025

The Journal of clinical investigation

The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression.

02-06-2025

Clinical genitourinary cancer

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

01-06-2025

British journal of cancer

Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.

01-06-2025

Clinical colorectal cancer

Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands.

01-06-2025

The Lancet. Oncology

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

01-06-2025

Cancer epidemiology

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

01-06-2025

The Lancet. Oncology

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study.

01-06-2025

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

01-06-2025

Contemporary clinical trials communications

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

01-06-2025

NAR genomics and bioinformatics

Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data.

01-06-2025

Journal of clinical pathology

Prognostic value of immunohistochemical markers of intratumoral hypoxia in pregnancy-associated breast cancer.

01-06-2025

Biomedical chromatography : BMC

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

01-06-2025

Maturitas

No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).

01-06-2025

European radiology

Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis.

01-06-2025

The Lancet. Oncology

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

01-06-2025

Gastroenterology

Reply.

01-06-2025

Breast (Edinburgh, Scotland)

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

01-06-2025

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.

01-06-2025

Oncology and therapy

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

01-06-2025

Journal of cancer survivorship : research and practice

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

01-06-2025

Journal of the National Cancer Institute

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

01-06-2025

The British journal of surgery

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

31-05-2025

NPJ breast cancer

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

29-05-2025

Annals of oncology : official journal of the European Society for Medical Oncology

Enfortumab Vedotin Plus Pembrolizumab in Untreated Locally Advanced or Metastatic Urothelial Carcinoma: 2.5-Year Median Follow-Up of the Phase III EV-302/KEYNOTE-A39 Trial.

29-05-2025

Journal of cancer survivorship : research and practice

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

28-05-2025

Therapeutic drug monitoring

Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) Phosphate: A Short Communication.

28-05-2025

European journal of epidemiology

Cancer risk after in utero exposure to diethylstilbestrol.

28-05-2025

EJNMMI research

Metabolic parameters on baseline and early [¹⁸F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.

28-05-2025

EBioMedicine

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

28-05-2025

Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study.

Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy.

Sleep quality and overall survival among cancer survivors in the Netherlands: A PROFILES registry study.

Toward the End of Planning Target Volume Margins With Online Adaptive Radiation Therapy.

Design, Synthesis, and Biological Implications of Autotaxin inhibitors with a Three-Point lock binding mode.

A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability.

Efficacy of encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the Dutch Melanoma Treatment Registry.

G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor.

Biomarker analysis and treatment dynamics following preoperative ipilimumab plus nivolumab in locally advanced urothelial cancer from the phase 1B NABUCCO study.

Post-processing steps improve generalisability and robustness of an MRI-based radiogenomic model for human papillomavirus status prediction in oropharyngeal cancer.

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

CD151 interacts with integrin beta 2 in B cell lymphomas.

Breast density changes after risk-reducing salpingo-oophorectomy in women with a pathogenic germline variant in BRCA1 or BRCA2.

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression.

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.

Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands.

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study.

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data.

Prognostic value of immunohistochemical markers of intratumoral hypoxia in pregnancy-associated breast cancer.

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).

Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis.

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Reply.

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

Enfortumab Vedotin Plus Pembrolizumab in Untreated Locally Advanced or Metastatic Urothelial Carcinoma: 2.5-Year Median Follow-Up of the Phase III EV-302/KEYNOTE-A39 Trial.

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) Phosphate: A Short Communication.

Cancer risk after in utero exposure to diethylstilbestrol.

Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

This site uses cookies

Metabolic parameters on baseline and early [¹⁸F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.